Anna V. Nikoghosyan

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.

The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.

Journal: International journal of radiation oncology, biology, physics

Published: June 03, 2019

Persistence of radiation-induced aberrations in patients after radiotherapy with C-ions and IMRT.

Persistence of radiation-induced aberrations in patients after radiotherapy with C-ions and IMRT.

Journal: Clinical and translational radiation oncology

Published: July 06, 2018

High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.

High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 01, 2015

Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.

Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.

Journal: Cancer

Published: February 17, 2015

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.

Journal: International journal of radiation oncology, biology, physics

Published: February 12, 2015

Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.

Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 25, 2014

Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis.

Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis.

Journal: BMC cancer

Published: May 20, 2014

Chromosome inversions in lymphocytes of prostate cancer patients treated with X-rays and carbon ions.

Chromosome inversions in lymphocytes of prostate cancer patients treated with X-rays and carbon ions.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 11, 2013

A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma.

A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma.

Journal: BMC cancer

Published: April 11, 2012

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.

Journal: Radiation oncology (London, England)

Published: December 11, 2011

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.

Journal: BMC cancer

Published: October 12, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026